I am writing this column about a week after the publication of the Human Genome Project data in Science (February 16, 2001) and Nature (February 15, 2001 ). One of the major findings that received a great deal of attention was the fact that the genome appears to contain only about 30,000 genes (Baltimore 2001) . Somewhat like the publication of Darwin's On the Origin of Species, this seems to denigrate the place of humans in the scheme of things. How can something as complex and wonderful as a human being manage to function with only about 5,000 more genes than a plant (Arabidopsis thaliana) (Bork & Copley 2001) ? For some people, this borders on the embarrassing. Of course, this estimate may turn out to be wrong, and there may be novel ways that 30,000 genes can translate into quite enough complexity to satisfy the most chauvinistic human (Gould 2001) . What is certain is that the years ahead will be exciting in the world of human genomics and its cousin proteomics, as more and more information comes to light on the genes and proteins that make us human.
But I don't think we should lose sight of all the other genomes that are also being explored, including some that are much smaller than the human genome, but still extremely interesting. I am referring specifically to bacterial genomes. More than 30 have now been published, which means that it's possible to compare bacterial genomes and see how the genetic makeup of a particular bacterial species relates to its life style. Not surprisingly, most of the bacterial genomes published so far belong to disease-causing organisms, in many cases, species that cause human disease. With this work, and other research on specific bacterial genes, researchers are in many cases gaining a better understanding of how bacteria manage to disrupt normal cell processes in their hosts while at the same time foiling the host's immune system. In no case is the picture of infection processes totally clear, but as more is learned it may be possible to find better ways to bring bacterial infections under control or even to prevent them.
Pseudomonas aeruginosa
The complete genome sequence for Pseudomonas aeruginosa was published last year (Greenberg 2000). As with most other such genomes, the sequence contained some surprises and also provided indications of how the organism might be brought under control. P. aeruginosa causes persistent lung infections in patients with cystic fibrosis and in those whose immune systems are compromised. In cystic fibrosis patients, the infection slowly damages more and more lung tissue, leading ultimately to death. The fact that the organism is resistant to antibiotics makes this a particularly difficult infection to deal with. The hope is that having the genome sequence will lead to the discovery of new approaches to treatment.
It turns out that while the human genome may be surprisingly small, the P. aeruginosa genome is unusually large. This is where having a number of genome sequences available makes useful comparisons possible. The P. aeruginosa genome is a third larger than that of E. coli, and it has about as many genes as that of the yeast Saccharomyces cerevisiae. The large size means there is a diversity of genes, particularly in two areas: regulation and pumping. About 10% of the genes contain sequences similar to those known to be involved in genetic regulation. This is in keeping with the general trend that the larger the bacterial genome, the larger the number of regulatory genes. Helicobacter pylori, a very specialized organism that colonizes the stomach and causes ulcers, has a tiny genome of which only about 1% of the genes appear to deal with regulation.
The large number of regulatory genes in P. aeruginosa seems consistent with its nutritional versatility; it can turn genes on and off as conditions require. The fact that this organism's genome also has genes for a number of pumps may help to explain its resistance to antibiotics. P. aeruginosa is one of the Gram-negative bacteria, many of which have pumps that remove antibiotics faster than these drugs can accumulate within the cells. The RND protein family of pumps can make bacteria impervious to antibiotics, and while P. aeruginosa was already known to have four RND pumps, sequences for two more have been identified in its genome sequence. There is some evidence that this bacterium creates biofilms in the lungs and that in this form it produces pumping systems; this would explain both its persistence and its resistance to drug therapy. Now that its genome has been sequenced, the next step in trying to bring P. aeruginosa under control is to analyze its gene expression under a variety of conditions; the U.S. Cystic Fibrosis Foundation has established a Cystic Fibrosis Bioinformatics Center to undertake this research.
